UPDATED: Labcorp is spinning out its clinical development unit in major shakeup - Endpoints News
7/28/2022 12:00:00 AM2 years 9 months ago
by Max Gelman, Tyler Patchen
by Max Gelman, Tyler Patchen
Labcorp announced this morning that it is spinning out most of its CRO business, eight years after its $6 billion Covance acquisition. Labcorp will keep its core business directed at diagnostic testing, the company said Thursday morning after the Wall Street …
Despite generics eating away at one of Bristol Myers Squibb’s highest sellers last year, Revlimid, CEO Giovanni Caforio maintained on Wednesday’s Q2 call that the company’s “foundation is strong” — a… [+672 chars]
full article...